Drugs / GADOXETIC ACID
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02854371 | Aug 2016 → Feb 2017 | cirrhosis of liver | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01575574 | Jul 2012 → Jul 2016 | hepatocellular carcinoma | Sara Varea | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GADOXETIC ACID | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01575574 ↗ |
| Modality | Diagnostic / imaging agent | “new contrast agent” NCT01575574 ↗ |
| Route | Intravenous | “administered intravenously at a rate of 1mL/sec” NCT02854371 ↗ |